Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3734800013 | Product containing only ponatinib (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3734801012 | Ponatinib only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2857691000001114 | Ponatinib (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2857701000001114 | Ponatinib | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ponatinib | Has active ingredient | Ponatinib | true | Inferred relationship | Existential restriction modifier | 1 | |
| Ponatinib | Is a | Product containing ponatinib | true | Inferred relationship | Existential restriction modifier | ||
| Ponatinib | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Ponatinib | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Ponatinib | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only ponatinib in oral dose form (medicinal product form) | Is a | True | Ponatinib | Inferred relationship | Existential restriction modifier | |
| Ponatinib 30mg tablets | Is a | True | Ponatinib | Inferred relationship | Existential restriction modifier | |
| Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet | Is a | True | Ponatinib | Inferred relationship | Existential restriction modifier | |
| Product containing precisely ponatinib (as ponatinib hydrochloride) 45 milligram/1 each conventional release oral tablet | Is a | True | Ponatinib | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR